Shahin Akhondzadeh
Biographic Data
| ID | 7053307 |
|---|---|
| NAME | Shahin Akhondzadeh |
| GIVEN NAMES | Shahin |
| FAMILY NAME | Akhondzadeh |
| SIGNATURE | AKHONDZADEH S |
| AFFILIATIONS | Roozbeh Hospital |
| ORCID | 0000-0002-2277-5101 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2005 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Substance of choice, impact of heroin or opium on treatment retention in a multicentre randomised controlled trial in Iran
Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial
Setting research priorities to achieve long-term health targets in Iran
BACKGROUND: In 2015, it was estimated that the burden of disease in Iran comprised of 19 million disability-adjusted life years (DALYs), 74% of which were due to non-communicable diseases (NCDs). The observed leading causes of death were cardiovascular diseases (41.9%), neoplasms (14.9%), and road traffic injuries (7.4%). Even so, the health research investment in Iran continues to remain limited. This study aims to identify national health resea…
A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders
Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial
Health-related quality of life of Iranian children with attention deficit/hyperactivity disorder
A Double-blind Placebo Controlled Trial of Piracetam Added to Risperidone in Patients with Autistic Disorder
Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: A double-blind, randomized pilot trial
No prominent works on this page.
Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: A double-blind, randomized pilot trial
A Double-blind Placebo Controlled Trial of Piracetam Added to Risperidone in Patients with Autistic Disorder
Health-related quality of life of Iranian children with attention deficit/hyperactivity disorder
Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial
A Double-Blind Placebo Controlled Trial of Ginkgo biloba Added to Risperidone in Patients with Autistic Disorders
Setting research priorities to achieve long-term health targets in Iran
BACKGROUND: In 2015, it was estimated that the burden of disease in Iran comprised of 19 million disability-adjusted life years (DALYs), 74% of which were due to non-communicable diseases (NCDs). The observed leading causes of death were cardiovascular diseases (41.9%), neoplasms (14.9%), and road traffic injuries (7.4%). Even so, the health research investment in Iran continues to remain limited. This study aims to identify national health resea…
Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial
Substance of choice, impact of heroin or opium on treatment retention in a multicentre randomised controlled trial in Iran
Medicine (8 works) · Psychiatry (7 works) · Internal Medicine (6 works) · Psychology (5 works) · Attention Deficit Hyperactivity Disorder (4 works) · Internal Medicine (4 works) · Placebo (4 works) · Adjunctive treatment (3 works) · Autism (3 works) · Autism Spectrum Disorder Research (3 works)